Chesterfield, MO, United States of America

Maire Helena Caparon

This inventor holds 27 USPTO granted patents and 1 published patent application, plus 1 CIPO patent, primarily in Hematopoietic Stem Cell Therapy. Top assignees: G.d. Searle & Company, Pharmacia Corporation, G.d. Searle LLC. Active years: 1997-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maire Helena Caparon. Retrieved from https://idiyas.com/inventor/maire-helena-caparon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 27 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.7

ph-index = 9

Forward Citations = 312(Granted Patents)


Company Filing History:


Years Active: 1997-2004

Loading Chart...
Loading Chart...
Areas of Expertise:
Hematopoietic Stem Cells
Interleukin-3
Fusion Proteins
Mutant Polypeptides
Ex-Vivo Expansion
Colony Stimulating Factors
Therapeutic Methods
Recombinant Production
Hematopoiesis
Multi-Lineage Production
Human Variants
Chimera Proteins
27 patents (USPTO):Explore Patents

Hello! I am delighted to present an article about the accomplished inventor Maire Helena Caparon.

Title: Unveiling the Innovations of Maire Helena Caparon

Introduction: Maire Helena Caparon, a prolific inventor hailing from Chesterfield, MO (US), has left an indelible mark in the world of patents with a staggering 27 inventions to his name.

Latest Patents:

1. **Fused G-CSF and IL-3 proteins and uses thereof:** Maire's groundbreaking work includes the creation of novel multi-functional hematopoietic receptor agonist proteins. These proteins, along with their encoding DNAs and methods of production and utilization, signify a leap forward in the field of biotechnology.

2. **Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells:** His recent patent revolutionizes the ex-vivo expansion of hematopoietic stem cells through recombinant human interleukin-3 variant proteins. These muteins, coupled with innovative pharmaceutical compositions and manufacturing processes, hold promise in advancing medical treatments.

Career Highlights: Maire has graced esteemed organizations with his expertise, including G.D. Searle & Company, where his innovative spirit thrived. His contributions have undoubtedly reshaped the landscape of biopharmaceutical inventions.

Collaborations: Throughout his illustrious career, Maire has collaborated with esteemed professionals such as S. Christopher Bauer and John Patrick McKearn. These partnerships have fueled creativity and led to remarkable scientific advancements.

Conclusion: In conclusion, Maire Helena Caparon's dedication to innovation and relentless pursuit of excellence have significantly impacted the realm of patents. His numerous accomplishments underscore his status as a trailblazing inventor whose legacy will continue to inspire generations to come.

If you have any more inquiries or require further information, feel free to ask!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…